1. Home
  2. ABUS

as 11-21-2024 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.

Founded: N/A Country:
United States
United States
Employees: N/A City: WARMINSTER
Market Cap: 725.9M IPO Year: N/A
Target Price: $5.50 AVG Volume (30 days): 837.4K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.43 EPS Growth: N/A
52 Week Low/High: $1.79 - $4.72 Next Earning Date: 11-06-2024
Revenue: $6,742,000 Revenue Growth: -69.69%
Revenue Growth (this year): -64.38% Revenue Growth (next year): -13.12%

ABUS Daily Stock ML Predictions

Share on Social Networks: